Jorge Insuasty
Corporate Officer/Principal chez PHILIP MORRIS INTERNATIONAL, INC.
Profil
Jorge Insuasty is currently the President-Vectura Fertin Pharma at Philip Morris International, Inc. and the President at Vectura Fertin Pharma, Inc. He previously worked as the Global Head-Development & Neuroscience at Novartis International AG and as the Vice President & Member-Global Leadership Team at Sanofi.
Dr. Insuasty holds a graduate degree from Université de Paris 5 René Descartes.
Postes actifs de Jorge Insuasty
| Sociétés | Poste | Début |
|---|---|---|
| PHILIP MORRIS INTERNATIONAL, INC. | Corporate Officer/Principal | 15/01/2021 |
| Vectura Fertin Pharma, Inc. | President | 01/01/2023 |
Anciens postes connus de Jorge Insuasty
| Sociétés | Poste | Fin |
|---|---|---|
Novartis International AG
 Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | - |
| SANOFI | Chief Tech/Sci/R&D Officer | 23/10/2014 |
Formation de Jorge Insuasty
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SANOFI | Health Technology |
| PHILIP MORRIS INTERNATIONAL, INC. | Consumer Non-Durables |
| Entreprise privées | 3 |
|---|---|
Novartis International AG
Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Health Technology |
| Université de Paris 5 René Descartes | Consumer Services |
| Vectura Fertin Pharma, Inc. |
